SynthesisJournal of the European Academy of Dermatology and Venereology : JEADV2020

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials.

H H van der Zee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.